These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 17595769)
1. In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent. Liu J; Towle MJ; Cheng H; Saxton P; Reardon C; Wu J; Murphy EA; Kuznetsov G; Johannes CW; Tremblay MR; Zhao H; Pesant M; Fang FG; Vermeulen MW; Gallagher BM; Littlefield BA Anticancer Res; 2007; 27(3B):1509-18. PubMed ID: 17595769 [TBL] [Abstract][Full Text] [Related]
2. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214 [TBL] [Abstract][Full Text] [Related]
3. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Loganzo F; Discafani CM; Annable T; Beyer C; Musto S; Hari M; Tan X; Hardy C; Hernandez R; Baxter M; Singanallore T; Khafizova G; Poruchynsky MS; Fojo T; Nieman JA; Ayral-Kaloustian S; Zask A; Andersen RJ; Greenberger LM Cancer Res; 2003 Apr; 63(8):1838-45. PubMed ID: 12702571 [TBL] [Abstract][Full Text] [Related]
4. Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol. Clark EA; Hills PM; Davidson BS; Wender PA; Mooberry SL Mol Pharm; 2006; 3(4):457-67. PubMed ID: 16889440 [TBL] [Abstract][Full Text] [Related]
5. Preclinical efficacy spectrum and pharmacokinetics of ixabepilone. Lee FY; Smykla R; Johnston K; Menard K; McGlinchey K; Peterson RW; Wiebesiek A; Vite G; Fairchild CR; Kramer R Cancer Chemother Pharmacol; 2009 Jan; 63(2):201-12. PubMed ID: 18350296 [TBL] [Abstract][Full Text] [Related]
6. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously. Gapud EJ; Bai R; Ghosh AK; Hamel E Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302 [TBL] [Abstract][Full Text] [Related]
7. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization. Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
10. Synthetic approaches to the microtubule stabilizing agent (-)-laulimalide. Crimmins MT Curr Opin Drug Discov Devel; 2002 Nov; 5(6):944-59. PubMed ID: 12478725 [TBL] [Abstract][Full Text] [Related]
11. Microtubule-stabilizing marine metabolite laulimalide and its derivatives: synthetic approaches and antitumor activity. Mulzer J; Ohler E Chem Rev; 2003 Sep; 103(9):3753-86. PubMed ID: 12964883 [No Abstract] [Full Text] [Related]
12. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945 [TBL] [Abstract][Full Text] [Related]
13. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps. Kasibhatla S; Baichwal V; Cai SX; Roth B; Skvortsova I; Skvortsov S; Lukas P; English NM; Sirisoma N; Drewe J; Pervin A; Tseng B; Carlson RO; Pleiman CM Cancer Res; 2007 Jun; 67(12):5865-71. PubMed ID: 17575155 [TBL] [Abstract][Full Text] [Related]
14. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice. Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185 [TBL] [Abstract][Full Text] [Related]
15. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383 [TBL] [Abstract][Full Text] [Related]
16. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo. Hofstetter B; Vuong V; Broggini-Tenzer A; Bodis S; Ciernik IF; Fabbro D; Wartmann M; Folkers G; Pruschy M Clin Cancer Res; 2005 Feb; 11(4):1588-96. PubMed ID: 15746064 [TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models. Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771 [TBL] [Abstract][Full Text] [Related]
18. Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795 [TBL] [Abstract][Full Text] [Related]
19. Microtubule-stabilizing agents based on designed laulimalide analogues. Mooberry SL; Randall-Hlubek DA; Leal RM; Hegde SG; Hubbard RD; Zhang L; Wender PA Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8803-8. PubMed ID: 15161976 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel, simplified analogues of laulimalide: modification of the side chain. Paterson I; Menche D; Håkansson AE; Longstaff A; Wong D; Barasoain I; Buey RM; Díaz JF Bioorg Med Chem Lett; 2005 May; 15(9):2243-7. PubMed ID: 15837302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]